Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome-Reference-Cited by-同舟云学术

Serum CXCL13, BAFF, IL-21 and IL-22 levels are related to disease activity and lymphocyte profile in primary Sjögren's syndrome

Published:2021-12-15 Issue:6 Volume:39 Page:131-139
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Loureiro-Amigo Jose¹,Franco-Jarava Clara²,Perurena-Prieto Janire²,Palacio Carlos³,Martínez-Valle Fernando¹,Soláns-Laqué Roser⁴

Affiliation:

1. Autoimmune Systemic Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d’Hebron, Barcelona, and Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

2. Immunology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.

3. Flow Cytometry Unit, Haematology Department, Hospital Universitari Vall d’Hebron, Barcelona, Spain.

4. Autoimmune Systemic Diseases Unit, Internal Medicine Department, Hospital Universitari Vall d’Hebron, Barcelona, and Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain. rsolanslaq@gmail.com

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Role of PD-1 in the Autoimmune Response: Insights into Its Implication in Systemic Lupus Erythematosus;International Journal of Molecular Sciences;2024-07-15

2. Advances in cellular and molecular pathways of salivary gland damage in Sjögren’s syndrome;Frontiers in Immunology;2024-07-10

3. Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology;Frontiers in Pharmacology;2024-05-17

4. Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren’s syndrome in mice by promoting TEC kinase degradation;Acta Pharmacologica Sinica;2024-05-14

5. Chemokines and lymphocyte homing in Sjögren’s syndrome;Frontiers in Immunology;2024-04-26